| [1] |
Based on optn data[EB/OL]. (2014-03-06).[http://optn.transplant.hrsa.gov.]
|
| [2] |
Djamali A, Kaufman DB, Ellis TM, et al. Diagnosis and management of antibody-mediated rejection:current status and novel approaches[J]. Am J Transplant, 2014, 14(2):255-271. doi: 10.1111/ajt.12589
|
| [3] |
Sui W, Huang L, Dai Y, et al. Proteomic profiling of renal allograft rejection in serum using magnetic bead-based sample fractionation and MALDI-TOF MS[J]. Clin Exp Med, 2010, 10(4):259-268. doi: 10.1007/s10238-010-0094-5
|
| [4] |
Zheng J, Ding X, Tian X, et al. Assessment of different biomarkers provides valuable diagnostic standards in the evaluation of the risk of acute rejection[J]. Acta Biochim Biophys Sin, 2012, 44(9):730-736. doi: 10.1093/abbs/gms056
|
| [5] |
Nair R, Agrawal N, Lebaeau M, et al. Late acute kidney transplant rejection:clinicopathological correlates and response to corticosteroid therapy[J]. Transplant Proc, 2009, 41(10):4150-4153. doi: 10.1016/j.transproceed.2009.09.074
|
| [6] |
Lo DJ, Weaver TA, Kleiner DE, et al. Chemokines and their receptors in human renal allotransplantation[J]. Transplantation, 2011, 91(1):70-77. doi: 10.1097/TP.0b013e3181fe12fc
|
| [7] |
衡宝利, 叶东明, 程云华, 等.肾移植急性排斥大鼠的血清NGAL和CXCL10表达及意义[J].实用医学杂志, 2014, 30(5):702-705. http://www.cnki.com.cn/Article/CJFDTOTAL-SYYZ201405010.htm
Heng BL, Ye DM, Cheng YH, et al. The significance of serum NGAL and CXCL10 expression of rats with acute rejection after renal transplantation[J]. J Pract Med, 2014, 30(5):702-705. http://www.cnki.com.cn/Article/CJFDTOTAL-SYYZ201405010.htm
|
| [8] |
Zhang Z, Kaptanoglu L, Tang Y, et al. IP-10-induced recruitment of CXCR3 host T cells is required for small bowel allograft rejection[J]. Gastroenterology, 2004, 126(3):809-818. doi: 10.1053/j.gastro.2003.12.014
|
| [9] |
Jenh CH, Cox MA, Cui L, et al. A selective and potent CXCR3 antagonist SCH 546738 attenuates the development of autoimmune diseases and delays graft rejection[J]. BMC Immunol, 2012, 13:2. doi: 10.1186/1471-2172-13-2
|
| [10] |
Hu H, Aizenstein BD, Puchalski A, et al. Elevation of CXCR3-binding chemokines in urine indicates acute renal-allograft dysfunction[J]. Am J Transplant, 2004, 4(3):432-437. doi: 10.1111/ajt.2004.4.issue-3
|
| [11] |
Romagnani P, Crescioli C. CXCL10:a candidate biomarker in transplantation[J]. Clin Chim Acta, 2012, 413(17/18):1364-1373. https://www.researchgate.net/publication/221862474_CXCL10_A_candidate_biomarker_in_transplantation
|
| [12] |
Wang W, Li XB, Yang XY, et al. Forkhead box protein 3 mRNA expression in the peripheral blood of kidney-transplant recipients with acute rejection[J]. Chin Med J, 2011, 124(12):1775-1778. http://www.cqvip.com/qk/85656x/201112/38613791.html
|
| [13] |
Nazari B, Amirzargar A, Nikbin B, et al. Comparison of the Th1, IFN-γ secreting cells and FoxP3 expression between patients with stable graft function and acute rejection post kidney transplantation[J]. Iran J Allergy Asthma Immunol, 2013, 12(3):262-268. http://d.wanfangdata.com.cn/OAPaper/oai_doaj-articles_ff00c644ff3e294eaa467c6c2245a3fe
|
| [14] |
Engela AU, Boer K, Roodnat JI, et al. Genetic variants of FOXP3 influence graft survival in kidney transplant patients[J]. Hum Immunol, 2013, 74(6):751-757. doi: 10.1016/j.humimm.2013.02.008
|
| [15] |
Dummer CD, Carpio VN, da Silva Loreto M, et al. Analysis of FOXP3 gene and protein expressions in renal allograft biopsies and their association with graft outcomes[J]. Ren Fail, 2013, 35(4):521-530. doi: 10.3109/0886022X.2013.766568
|
| [16] |
Kollins D, Stoelcker B, Hoffmann U, et al. FOXP3+ regulatory T-cells in renal allografts:correlation with long-term graft function and acute rejection[J]. Clin Nephrol, 2011, 75(2):91-100. http://www.oalib.com/references/14048989
|
| [17] |
Shang Y, Ju W, Kong Y, et al. Performance of polymerase chain reaction techniques detecting perforin in the diagnosis of acute renal rejection:a Meta-analysis[J]. PLoS One, 2012, 7(6):e39610. doi: 10.1371/journal.pone.0039610
|
| [18] |
Corrales-Tellez E, Vu D, Shah T, et al. Association between granzyme B and perforin Ⅰ polymorphisms and allograft outcomes in Hispanic kidney transplant recipients[J]. Clin Transplant, 2013, 27(3):E308-E315. doi: 10.1111/ctr.2013.27.issue-3
|
| [19] |
Shang Y, Ju W, Kong Y, et al. Performance of polymerase chain reaction techniques detecting granzyme B in the diagnosis of acute renal rejection:a Meta-analysis[J]. Transplantation, 2013, 95(9):1105-1112. doi: 10.1097/TP.0b013e318287d818
|
| [20] |
van Ham SM, Heutinck KM, Jorritsma T, et al. Urinary granzyme A mRNA is a biomarker to diagnose subclinical and acute cellular rejection in kidney transplant recipients[J]. Kidney Int, 2010, 78(10):1033-1040. doi: 10.1038/ki.2010.274
|
| [21] |
Rekers NV, Bajema IM, Mallat MJ, et al. Quantitative polymerase chain reaction profiling of immunomarkers in rejecting kidney allografts for predictin gresponse to steroid treatment[J]. Transplantation, 2012, 94(6):596-602. doi: 10.1097/TP.0b013e31825db651
|
| [22] |
Iwase H, Kobayashi T, Kodera Y, et al. Clinical significance of regulatory T-cell-related gene expression in peripheral blood after renal transplantation[J]. Transplantation, 2011, 91(2):191-198. doi: 10.1097/TP.0b013e3181ffbab4
|
| [23] |
Wang D, Wu W, Yang S, et al. Post-transplant monitoring of soluble CD30 level as predictor of graft outcome:a single center experience from China[J]. Transpl Immunol, 2012, 27(4):146-150. doi: 10.1016/j.trim.2012.10.002
|
| [24] |
Shooshtarizadeh T, Mohammadali A, Ossareh S, et al. Relation between pretransplant serum levels of soluble CD30 and acute rejection during the first 6 months after a kidney transplant[J]. Exp Clin Transplant, 2013, 11(3):229-233. doi: 10.6002/ect
|
| [25] |
Billing H, Sander A, Süsal C, et al. Soluble CD30 and ELISA-detected human leukocyte antigen antibodies for the prediction of acute rejection in pediatric renal transplant recipients[J]. Transpl Int, 2013, 26(3):331-338. doi: 10.1111/tri.2013.26.issue-3
|
| [26] |
Hirt-Minkowski P, Roth M, H nger G, et al. Soluble CD30 correlates with clinical but not subclinical renal allograft rejection[J]. Transpl Int, 2013, 26(1):75-83. doi: 10.1111/j.1432-2277.2012.01578.x
|
| [27] |
Oetting WS, Rogers TB, Krick TP, et al. Urinary beta2-microglobulin is associated with acute renal allograft rejection[J]. Am J Kidney Dis, 2006, 47(5):898-904. doi: 10.1053/j.ajkd.2006.01.034
|
| [28] |
Schaub S, Wilkins JA, Antonovici M, et al. Proteomic-based identification of cleaved urinary beta2-microglobulin as a potential marker for acute tubular injury in renal allografts[J]. Am J Transplant, 2005, 5(4 Pt 1):729-738. http://www.academia.edu/4008761/Proteomic-Based_Identification_of_Cleaved_Urinary_beta2-microglobulin_as_a_Potential_Marker_for_Acute_Tubular_Injury_in_Renal_Allografts
|
| [29] |
Schaub S, Mayr M, H nger G, et al. Detection of subclinical tubular injury after renal transplantation:comparison of urine protein analysis with allograft histopathology[J]. Transplantation, 2007, 84(1):104-112. doi: 10.1097/01.tp.0000268808.39401.e8
|
| [30] |
Astor BC, Muth B, Kaufman DB, et al. Serum β2-microglobulin at discharge predicts mortality and graft loss following kidney transplantation[J]. Kidney Int, 2013, 84(4):810-817. doi: 10.1038/ki.2013.172
|
| [31] |
Devarajan P. Neutrophil gelatinase-associated lipocalin (NGAL):a new marker of kidney disease[J]. Scand J Clin Lab Invest Suppl, 2008, 241:89-94. http://cat.inist.fr/?aModele=afficheN&cpsidt=20500013
|
| [32] |
Heyne N, Kemmner S, Schneider C, et al. Urinary neutrophil gelatinase-associated lipocalin accurately detects acute allograft rejection among other causes of acute kidney injury in renal allograft recipients[J]. Transplantation, 2012, 93(12):1252-1257. doi: 10.1097/TP.0b013e31824fd892
|
| [33] |
Kohei J, Ishida H, Tanabe K, et al. Neutrophil gelatinase-associated lipocalin is a sensitive biomarker for the early diagnosis of acute rejection after living-donor kidney transplantation[J]. Int Urol Nephrol, 2013, 45(4):1159-1167. doi: 10.1007/s11255-012-0321-y
|
| [34] |
Field M, Lowe D, Cobbold M, et al. The use of NGAL and IP-10 in the prediction of early acute rejection in highly sensitized patients following HLA-incompatible renal transplantation[J]. Transpl Int, 2014, 27(4):362-370. doi: 10.1111/tri.2014.27.issue-4
|
| [35] |
Ting YT, Coates PT, Marti HP, et al. Urinary soluble HLA-DR is a potential biomarker for acute renal transplant rejection[J]. Transplantation, 2010, 89(9):1071-1078. doi: 10.1097/TP.0b013e3181d15492
|
| [36] |
de Oliveira JG, Xavier PD, Sampaio SM, et al. The synthesis by fine-needle aspiration biopsy cultures of IL-7, IL-16 and IL-18 is significantly associated with acute rejection in kidney transplants[J]. Nephron, 2002, 92(3):622-628. doi: 10.1159/000064106
|
| [37] |
Striz I, Krasna E, Honsova E, et al. Interleukin 18(IL-18) upregulation in acute rejection of kidney allograft[J]. Immunol Lett, 2005, 99(1):30-35. doi: 10.1016/j.imlet.2005.01.010
|
| [38] |
刘哲, 王龙信, 王福利, 等.肾移植术后血清IL-18的动态监测及临床意义[J].细胞与分子免疫学杂志, 2008, 24(11):1082-1083, 1086. http://d.wanfangdata.com.cn/Periodical/xbyfzmyxzz200811014
Liu Z, Wang LX, Wang FL, et al. Significance of sequential monitoring of serum IL-18 in renal allograft recipients[J]. Chin J Cell Mol Immunol, 2008, 24(11):1082-1083, 1086. http://d.wanfangdata.com.cn/Periodical/xbyfzmyxzz200811014
|
| [39] |
Alachkar N. Serum and urinary biomarkers in acute kidney transplant rejection[J]. Nephrol Ther, 2012, 8(1):13-19. doi: 10.1016/j.nephro.2011.07.409
|
| [40] |
Freue GV, Sasaki M, Meredith A, et al. Proteomic signatures in plasma during early acute renal allograft rejection[J]. Mol Cell Proteomics, 2010, 9(9):1954-1967. doi: 10.1074/mcp.M110.000554
|
WeChat Subscription Account
Wechat Service Account
Supported by:
Beijing Renhe Information Technology Co. Ltd
DownLoad: